FLUORIDE SUBSTITUTION OF VITAMIN-D ANALOGS AT C-26 AND C-27 - ENHANCEMENT OF ACTIVITY OF 25-HYDROXYVITAMIN-D BUT NOT OF 1,25-DIHYDROXYVITAMIN-D ON BONE AND INTESTINE INVITRO
- 1 January 1984
- journal article
- research article
- Vol. 229 (1) , 9-13
Abstract
A series of analogs of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] with multiple F substitutions in positions 26 and 27 were tested for their activities in competing with 1,25-(OH)2DS3 for binding to partially purified chick intestinal cytosol; in stimulating resorption of fetal rat limb bones in vitro; and in competing with 25-hydroxyvitamin D3 for binding sites in rat plasma. The relative potencies of 26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3, 26,26,26-trifluoro-25-hydroxyvitamin D3, 27-nor-26,26,26-trifluoro-25-hydroxyvitamin D3 and 25-hydroxyvitamin D3 in competing for intestinal cytosolic binding were 17:11:1:1. The relative potencies of the same series of compounds on stimulating resorption of fetal rat bones was 25:21:9:1. The relative ability of these 4 compounds to compete for plasma binding sites was 0.3:0.3:0.4:1.0. Multiple F substitution in the vicinity of the 25-hydroxyl group can markedly enhance the direct effects of 25-hydroxyvitamin D3 on its target tissues. This is postulated to result from the electronegativity of the F which increases the acidity of the 25-hydroxyl group and enhances its affinity for the receptor. In contrast to the effects seen with the 25-hydroxyvitamin D3 analogs, multiple F substitution in positions 26 and 27 did not enhance the activity of 1,25-(OH)2D3 on either cytosolic binding or bone resorption. Presumably, this is because biological activity, expressed in terms of affinity for the receptor, is already optimal in the 1,25-(OH)2D3 structure. The relative activities of the 26,27-hexafluoro derivative and 1,25-(OH)2D3 in competition for the plasma binding sites was 0.4:1.0. With respect to in vitro bone resorbing and intestinal receptor binding potency, no compound exceeded 1,25-(OH)2D3.This publication has 14 references indexed in Scilit:
- A fluorinated vitamin D3 analog with biopotency greater than 1α,25-dihydroxy vitamin D3Biochemical and Biophysical Research Communications, 1980
- An in vitro study of the stability of the chicken intestinal cytosol 1,25-dihydroxyvitamin D3-specific receptorArchives of Biochemistry and Biophysics, 1980
- Bioassay of 1,25-dihydroxyvitamin D in human plasma purified by partition, alkaline extraction, and high-pressure chromatographyAnalytical Biochemistry, 1980
- 24,24-Difluoro-1,25-dihydroxyvitamin D3: In vitro production, isolation, and biological activityArchives of Biochemistry and Biophysics, 1980
- Evidence for the metabolism of 24R-hydroxy-25-fluorovitamin D3 and 1α-hydroxy-25-fluorovitamin D3 to 1α,24R-dihydroxy-25-fluorovitamin D3Archives of Biochemistry and Biophysics, 1979
- Determination of vitamin D and its metabolites in plasma from normal and anephric manBiochemical Journal, 1979
- Synthesis and biological activity of 24-hydroxy-25-fluorovitamin D3. A highly potent mediator of calcium metabolism.Journal of Biological Chemistry, 1979
- The synthesis and activity in vitro of 25-masked-1α-hydroxylated vitamin D3 analogsSteroids, 1978
- BONE-RESORBING ACTIVITY OF ANALOGS OF 25-HYDROXYCHOLECALCIFEROL AND 1,25-DIHYDROXYCHOLECALCIFEROL - EFFECTS OF SIDE-CHAIN MODIFICATION AND STEREOISOMERIZATION ON RESPONSES OF FETAL RAT BONES INVITRO1976
- Bone Resorption in Tissue Culture. Factors Influencing the Response to Parathyroid Hormone *Journal of Clinical Investigation, 1965